Oppenheim's sign

From WikiMD's WELLNESSPEDIA


Oppenheim's sign
Synonyms
Pronounce N/A
Specialty Neurology
Symptoms Plantar reflex
Complications N/A
Onset N/A
Duration N/A
Types N/A
Causes Upper motor neuron lesion
Risks N/A
Diagnosis Neurological examination
Differential diagnosis Babinski sign, Chaddock's sign, Gordon's sign
Prevention N/A
Treatment
Medication N/A
Prognosis
Frequency
Deaths N/A


``` This template provides a structured summary of the medical condition known as Oppenheim's sign, which is a clinical sign used in neurology to assess the integrity of the corticospinal tract. It is part of the neurological examination and is related to the plantar reflex. The presence of Oppenheim's sign can indicate an upper motor neuron lesion, similar to other signs such as the Babinski sign, Chaddock's sign, and Gordon's sign. Oppenheim's sign is a medical sign often used in neurology to test for pyramidal tract dysfunction. It is named after the German neurologist Hermann Oppenheim, who first described it in 1884.

Description[edit]

The Oppenheim's sign is elicited by applying downward pressure along the medial side of the tibia. A positive sign is indicated by the involuntary flexion of the hip and knee.

Clinical significance[edit]

A positive Oppenheim's sign suggests a lesion of the corticospinal tract, often due to conditions such as multiple sclerosis, amyotrophic lateral sclerosis, or stroke. However, it is not specific and can be seen in other neurological disorders.

See also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.